Among specific collaborations supported by the capability are relationships with a wide range of academic institutions and universities.
The Jenner Institute was founded in November 2005 to develop innovative vaccines against major global diseases. Uniquely it focuses both on diseases of humans and livestock and tests new vaccine approaches in parallel in different species. A major theme is translational research involving the rapid early-stage development and assessment of new vaccines in clinical trials.
The Institute comprises the research activities of over 30 Jenner Investigators who head leading research groups spanning human and veterinary vaccine research and development. Together the Institute Investigators comprise one of the largest non-profit sector research and development activities in vaccinology.
Jenner Institute Investigators, through the support of many funders, are developing new vaccine candidates against major global infectious diseases. New vaccines against malaria, tuberculosis and HIV are currently in field trials in the developing world. Research is also underway on livestock vaccines against foot and mouth disease, avian influenza, bovine tuberculosis and other major causes of economic loss.
The Institute is a partnership between the University of Oxford and the The Pirbright Institute and is the successor to the former Edward Jenner Institute for Vaccine Research. The Institute is supported by the Jenner Vaccine Foundation, a UK registered charity and advised by the Jenner Institute Scientific Advisory Board.
The Roslin Institute is one of the National Institutes of Bioscience which receives strategic investment funding from the Biotechnology and Biological Sciences Research Council. It is located on the Easter Bush Campus with the Royal (Dick) School of Veterinary Studies, and is part of the College of Medicine and Veterinary Medicine, University of Edinburgh. Its mission is to gain fundamental understanding of genetic, cellular, organ and systems bioscience underpinning common mechanisms of animal development and pathology, and to use this knowledge to prevent and treat important veterinary diseases and develop sustainable farm animal production systems.
We also have a longstanding relationship strategic collaboration with The Roslin Institute, through which we plan to exploit knowledge of key events in virus-host interactions to identify candidate genes to edit or introduce for resistance, using cell-based assays to guide decisions to modify animals at Roslin for evaluation at Pirbright.
The National Avian Research Facility (NARF) was founded in 2013. It is supported by the University of Edinburgh, BBSRC, Roslin Foundation and Wellcome Trust and provides the UK with a national resource for the study of avian biology, genetics, infection and disease. NARF is a partnership between The Roslin Institute and The Pirbright Institute, both of which are National Institutes of Bioscience funded strategically by the BBSRC.
Our mission is to improve bird health and welfare, in particular of chickens, through research into host-pathogen interactions, avian physiology, developmental biology and genetics, utilising state-of-the-art technologies to include transgenics and bioinformatics.